Skip to main content

Table 7 The frequency of AE scores in the two groups

From: Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients

Score of AE

Brolucizumab group

Aflibercept group

Total number of injections in all patients

262

354

Total number of AE reported

219

314

Score 1

195 (89.0%)

277 (88.2%)

Score 2

14 (6.4%)

35 (11.2%)

Score 3

9 (4.1%)

2 (0.64%)

Score 4

1 (0.46%)

0